Literature DB >> 76750

Manchester regional breast study. Preliminary results.

J P Lythgoe.   

Abstract

1020 patients with early breast cancer were treated between March, 1970, and October, 1975, according to a prospective clinical trial. The results have been recorded after a follow-up of two to seven years. 713 cases of clinical stage-1 cancer were randomly allocated to treatment by simple mastectomy and postoperative radiotherapy, or simple mastectomy alone. There was no statistically significant difference in overall survival or in survival without distant metastases between the two groups. There was a significant reduction in the incidence of local recurrence in those who had received early postoperative radiotherapy compared with those who had not. 307 cases of clinical stage-11 cancer were randomly allocated to treatment by simple mastectomy and postoperative radiotherapy or radical mastectomy alone. There was no statistically significant difference in survival or in the incidence of local recurrence or distant metastases between the two groups.

Entities:  

Mesh:

Year:  1978        PMID: 76750     DOI: 10.1016/s0140-6736(78)90859-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Treatment of early breast cancer with primary radiation therapy: rationale, results, and techniques.

Authors:  J B Weissberg; L R Prosnitz
Journal:  Bull N Y Acad Med       Date:  1982-03

2.  Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer.

Authors:  A P Forrest; H J Stewart; M M Roberts; R J Steele
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

Review 3.  Conservative management of breast cancer: a review of British controlled trials.

Authors:  A P Forrest
Journal:  Ann R Coll Surg Engl       Date:  1980-01       Impact factor: 1.891

Review 4.  Axillary treatment for operable primary breast cancer.

Authors:  Nathan Bromham; Mia Schmidt-Hansen; Margaret Astin; Elise Hasler; Malcolm W Reed
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

5.  Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.

Authors:  J C van der Linden; J P Baak; J Lindeman; J Hermans; C J Meyer
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

Review 6.  [Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?].

Authors:  F K Böhler; H Eiter; W Rhomberg
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

7.  Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: the Southeastern Cancer Study Group experience.

Authors:  E Velez-Garcia; M Moore; C L Vogel; V Marcial; A Ketcham; A Bartolucci; C Liu; R Smalley
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

8.  Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.

Authors:  G Ribeiro; M K Palmer
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

9.  Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.

Authors:  H C van der Linden; J P Baak; J Lindeman; J Hermans; C J Meyer
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

10.  Prognosis based on primary breast carcinoma instead of pathological nodal status.

Authors:  S Ménard; R Bufalino; F Rilke; N Cascinelli; U Veronesi; M I Colnaghi
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.